BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4986737)

  • 1. Primary drug resistance in tuberculosis.
    Katz S
    JAMA; 1970 Jun; 212(12):2113-4. PubMed ID: 4986737
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. X. September 1970 to September 1973.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1974 Jul; 110(1):95-8. PubMed ID: 4209360
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental tuberculosis in mice, a model for the study of antitubercular chemotherapy].
    Rist N
    Arch Roum Pathol Exp Microbiol; 1971 Jun; 30(2):295-6. PubMed ID: 5004388
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary drug resistance in children. Drug susceptibility of strains of M. tuberculosis isolated from children during the years 1969 to 1972 at the Kings County Hospital Medical Center of Brooklyn.
    Steiner P; Rao M; Goldberg R; Steiner M
    Am Rev Respir Dis; 1974 Jul; 110(1):98-100. PubMed ID: 4209361
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoniazid-resistant cavitary tuberculosis in a physician following isoniazid prophylaxis.
    Karchmer TB; Phipps JD; Giannetta ET; Farr BM
    Infect Control Hosp Epidemiol; 2002 Oct; 23(10):622-5. PubMed ID: 12400895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs].
    Volkon VM; Shrentsel' OA
    Probl Tuberk; 1973; 51(6):28-31. PubMed ID: 4202910
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evolution of antibiograms of bacilli persisting under treatment in the sanatorium].
    Marion L
    Rev Tuberc Pneumol (Paris); 1967; 31(6):785-808. PubMed ID: 4317451
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug resistance in tuberculosis control.
    Shimao T
    Tubercle; 1987 Jun; 68(2 Suppl):5-18. PubMed ID: 3120383
    [No Abstract]   [Full Text] [Related]  

  • 13. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania].
    Placenti A
    Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary drug resistance in tuberculosis.
    Tizes R; Zaki MH; Katz S
    JAMA; 1970 Dec; 214(10):1887-8. PubMed ID: 4994250
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-course chemotherapy for pulmonary tuberculosis.
    Fox W; Mitchison DA
    Am Rev Respir Dis; 1975 Mar; 111(3):325-53. PubMed ID: 47233
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1970 Sep; 102(3):347-55. PubMed ID: 4989604
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J; Holecková R; Rozánek R; Starosta V; Strnad M; Sebests J; Strusa V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965; 8(5):589-92. PubMed ID: 4955225
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bacteriological and clinical aspects of the restoration of drug sensitivity of formerly resistant Mycobacterium cultures].
    Rudoĭ NM; Bochkov EN
    Probl Tuberk; 1973; 51(10):24-6. PubMed ID: 4206103
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.